Michael Gutch

Insider Reports History

Entity
Individual
Location
C/O Albireo Pharma, Inc., 50 Milk Street, 16 Th Floor, Boston, MA
Signature
/s/ Jason Duncan, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Gutch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entasis Therapeutics Holdings Inc. Chief Financial Officer and Chief Business Officer Employee Stock Option (Right to Buy) 43.5K Jul 16, 2021 Direct
ALBIREO PHARMA, INC. Director Stock Option (right to buy) 0 Mar 2, 2023 Direct

Insider Reports Filed by Michael Gutch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALBO ALBIREO PHARMA, INC. Mar 2, 2023 7 $0 4 Mar 2, 2023 Director
ALBO ALBIREO PHARMA, INC. Jun 24, 2022 1 $0 4 Jun 28, 2022 Director
ETTX Entasis Therapeutics Holdings Inc. Jan 18, 2022 1 $0 4 Jan 19, 2022 Chief Financial Officer and Chief Business Officer
ETTX Entasis Therapeutics Holdings Inc. Nov 2, 2021 1 -$10.8K 4 Nov 3, 2021 CFO and Chief Business Officer
ETTX Entasis Therapeutics Holdings Inc. Oct 19, 2021 2 -$12K 4 Oct 20, 2021 Chief Financial Officer and Chief Business Officer
ETTX Entasis Therapeutics Holdings Inc. Jul 16, 2021 6 $0 4 Feb 15, 2022 Chief Financial Officer and Chief Business Officer
ALBO ALBIREO PHARMA, INC. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director